Algo version: 0.98b
Viridian Therapeutics Inc is listed at the LSE Exchange
Viridian Therapeutics Inc [0K1R.L]
LSE Sector: Healthcare Industry:Biotechnology

Is Viridian Therapeutics Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Viridian Therapeutics Inc 10 years ago, but if you had invested on Thursday 7th of May 2020 when the price was $9.15, you would have made a profit of $11.29 per share or 123.39%

No, the average daily trading liquidity for Viridian Therapeutics Inc is $682 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Viridian Therapeutics Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Viridian Therapeutics Inc to be medium [0.7 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.